No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: For what it’s worth
Reply New Message
Prev Message Back To Forum Threaded View Next Message

I'm wondering what the smart money play is here for Zenith:

1.  Outright sale to (ex) Pfizer

2.  Pfizer then controls sales to competitors to aid their combo drugs as several biopharms are going to want this.  Could be MAJOR leverage with billions in dollars of treatment extensions at play  

3.  Keep all rights and sell to each biopharm for combo usage for decades

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply